Fundraising Fox

Holobiome, Inc.

Boston, US · Founded 2015 · Delaware corporation · 7 known investors

holobiome.org ↗

Holobiome is a biotechnology company focused on the gut microbiome and its connection to the nervous system, working in areas such as microbiology, computational biology, and neuroscience. Its work involves discovering and developing microbiome-based therapeutics.

AI & Machine LearningBiotechHealthtechin /holobiome@Holobiome_Inc

Founders & leadership

PS
Philip StrandwitzCo-founder & Director, Chief Executive Officer
IC
Iain ChessellDirector
ML
Michael LaFleurExecutive Officer
KL
Kim LewisCo-founder, Director
ML
Mike La FleurPresident, Co-founder, Director
JL
Joan LaRovereDirector

Investors · 7

Able PartnersNew York City · $500K – $3M
Bantam GroupWestwood
Healthtech CapitalSilicon Valley
iSelect FundSt. Louis · $250K – $2M
Pace VenturesBerlin · $550K – $1.6Mvia Marius Swart · inferred
Deep FuturereportedSeattlevia Pablos Holman · inferred
Service Provider CapitalreportedVail

Reported raises · per SEC filings

Form D private placements
▶$10MraisedJul 2026 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Philip StrandwitzExecutive Officer, Director
  • Iain ChessellDirector
  • Joan LaRovereDirector
  • Michael LaFleurExecutive Officer
Offering amount
$10M
Amount sold
$10M
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.6MraisedMar 2024 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Philip StrandwitzExecutive Officer, Director
  • Iain ChessellDirector
  • Michael LaFleurExecutive Officer
  • Joan LaRovereDirector
Offering amount
$9.4M
Amount sold
$6.6M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedFeb 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael LafleurDirector
  • Kim LewisDirector
  • Philip StrandwitzExecutive Officer, Director
  • Ian ChessellDirector
Offering amount
$2M
Amount sold
$300K
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$625KraisedDec 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Phil StrandwitzExecutive Officer, Director
  • Michael LafleurDirector
  • Kim LewisDirector
  • Iain ChessellDirector
Offering amount
$1.3M
Amount sold
$625K
First sale
Dec 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.